Pharma industry, due to its direct influence on human health and public social healthcare, is a critical and strategic business sector with complicated operations and value chain. Such an industry requires huge investments from early R&D stages to distribution and patient care. Pharma industry market volume is more than $ 600 billion and turnover of the industry is quite high.
To meet the critical and increasing demands of Pharma industry requirements to a reliable end-to-end and seamless value chain management platform, SYNCHRONIUM® invested in developing an ultimate solution, called “Elixir™”.
SYNCHRONIUM® team have outstanding working background with world-class pharma companies including Novartis, Sanofi, Merck, gsk, and pharma product distributors in Europe and MENA which gives them a proper insight from the industry requirements in seamless management of pharma products value chain management.
Elixir™ has been developed successfully and passed proof of concept phase, however, we are testing it in some local companies to make it properly compatible with various circumstances and scenarios.
Elixir™ is one of the platform startups of SynchroSphere™ being supported by InnovaNetwork™. If you’re interested to participate in Elixir™ further developments, opportunities are available by SynchroVentures™.